Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938886 · ClinicalTrials.gov registry record · Phase 2
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
A Phase 2 study of Cigarette Smoking and Hazardous Drinking, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00938886 is a Phase 2 study of Cigarette Smoking and Hazardous Drinking that has completed, run by Brown University. The registered enrollment target is 150 participants, below the 173-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00938886, a Phase 2 study of Cigarette Smoking and Hazardous Drinking, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
To test whether naltrexone compared to placebo can reduce heavy drinking and improve smoking cessation outcomes in heavy drinkers seeking smoking cessation treatment.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naltrexone
Study Locations (1)
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00938886
The ClinicalTrials.gov registry entry for NCT00938886 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 173-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (13% lower). The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00938886 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00938886 about?
NCT00938886 is a clinical study titled "Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment". To test whether naltrexone compared to placebo can reduce heavy drinking and improve smoking cessation outcomes in heavy drinkers seeking smoking cessation treatment.
What is the current status of trial NCT00938886?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2009-10. Estimated completion is 2015-12.
What conditions does trial NCT00938886 study?
This clinical trial studies the following conditions: Cigarette Smoking, Hazardous Drinking.
What interventions are being tested in trial NCT00938886?
The interventions under investigation include: Placebo (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00938886?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00938886 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
RECRUITING · Phase 2
-
Semaglutide for Post-Smoking Cessation Weight Management
RECRUITING · Phase 2
-
Treating Smokers With Mental Illness
COMPLETED · Phase 2
-
E-cigarette Nicotine Study
COMPLETED · Phase 2
-
Treatment of Smoking Among Individuals With PTSD
COMPLETED · Phase 2
-
Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.